Abbott investigates cyber incident in Cancer Diagnostics unit

Abbott Laboratories is investigating a cyber incident where unauthorized access occurred to a limited number of internal systems within its Cancer Diagnostics business. The company stated that this incident does not impact any business operations, product availability, manufacturing, or laboratory operations, nor its ability to serve patients.

Abbott confirmed that no other Abbott businesses, sites, or systems are affected. The company also clarified that the legacy Exact Sciences systems are separate from Abbott's. Upon learning of the incident, Abbott took immediate steps to address the situation.

The healthcare company has engaged leading third-party cybersecurity experts and law enforcement agencies to investigate. They are working diligently to further investigate the information accessed and resolve the issue. Abbott has not disclosed the exact nature or extent of the data accessed.

Based on current information, Abbott does not expect any material impact on its business or financial results. The company reiterated its commitment to protecting its systems and data and will continue to closely monitor its systems.